{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T23:55:38Z","timestamp":1715558138298},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1007\/bf01910317","type":"journal-article","created":{"date-parts":[[2005,7,31]],"date-time":"2005-07-31T09:59:41Z","timestamp":1122803981000},"page":"189-194","source":"Crossref","is-referenced-by-count":1,"title":["Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors"],"prefix":"10.1007","volume":"71","author":[{"given":"A.","family":"Casonato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pontara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bertomoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Dannhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Secchiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01910317_CR1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","volume":"70","author":"ZM Ruggeri","year":"1987","unstructured":"Ruggeri ZM, Zimmerman TS (1987) Von Willebrand factor and von Willebrand disease. Blood 70:895\u2013904","journal-title":"Blood"},{"key":"BF01910317_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.1983.tb02165.x","volume":"55","author":"LW Hoyer","year":"1983","unstructured":"Hoyer LW, Rissa CR, Tuddenham EGD, Carta CA, Armitage H, Rotblat F (1983) Von Willebrand factor multimeric patterns in von Willebrand disease. Br J Haematol 55:493\u2013507","journal-title":"Br J Haematol"},{"key":"BF01910317_CR3","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V57.6.1140.1140","volume":"57","author":"ZM Ruggeri","year":"1981","unstructured":"Ruggeri ZM, Zimmerman TS (1981) The complex multimeric composition of factor VIII\/von Willebrand factor. Blood 57:1140\u20131143","journal-title":"Blood"},{"key":"BF01910317_CR4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","volume":"65","author":"ZM Ruggeri","year":"1980","unstructured":"Ruggeri ZM, Zimmerman TS (1980) Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets. J Clin Invest 65:1318\u20131324","journal-title":"J Clin Invest"},{"key":"BF01910317_CR5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","volume":"302","author":"ZM Ruggeri","year":"1980","unstructured":"Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS (1980) Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 302:1047\u20131051","journal-title":"N Engl J Med"},{"key":"BF01910317_CR6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI114775","volume":"86","author":"L Marco De","year":"1990","unstructured":"De Marco L, Mazzuccato M, De Roia D, Casonato A, Federnici AB, Girolami A, Ruggeri ZM (1990) Distinct abnormalities in the interaction of purified IIA and IIB von Willebrand factor with the two platelet binding sites, glycoproteins Ib and IIb-IIIa. J Clin Invest 86:785\u2013792","journal-title":"J Clin Invest"},{"key":"BF01910317_CR7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI113095","volume":"80","author":"L Marco De","year":"1987","unstructured":"De Marco L, Mazzuccato M, Del Ben MG, Budde U, Federici AB, Girolami A, Ruggeri ZM (1987) Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin: role of platelet activation, fibrinogen and two distinct membrane receptors. J Clin Invest 80:475\u2013482","journal-title":"J Clin Invest"},{"key":"BF01910317_CR8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI112394","volume":"77","author":"TS Zimmerman","year":"1986","unstructured":"Zimmerman TS, Dent, JA, Ruggeri ZM, Nannini NH (1986) Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual diformers (type IIC, IID and IIE). J Clin Invest 77:947\u2013951","journal-title":"J Clin Invest"},{"key":"BF01910317_CR9","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","volume":"87","author":"JA Dent","year":"1990","unstructured":"Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Nat Acad Scie USA 87:6306\u20136310","journal-title":"Proc Nat Acad Scie USA"},{"key":"BF01910317_CR10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI115376","volume":"88","author":"JA Dent","year":"1991","unstructured":"Dent JA, Galbusera M, Ruggeri ZM (1991) Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 88:774\u2013782","journal-title":"J Clin Invest"},{"key":"BF01910317_CR11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI112843","volume":"79","author":"DS Berkowitz","year":"1987","unstructured":"Berkowitz DS, Dent J, Roberts JR, Fujimura Y, Plow EE, Titani K, Ruggeri ZM, Zimmerman TS (1987) Epitope mapping of the von Willebrand factor subunits distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. J Clin Invest 79:524\u2013531","journal-title":"J Clin Invest"},{"key":"BF01910317_CR12","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1073\/pnas.82.17.5968","volume":"82","author":"HR Gralnick","year":"1985","unstructured":"Gralnick HR, Williams SB, McKeown LP, Maisonneuve PH, Jenneau C, Sultan Y, Rick ME (1985) In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIA von Willebrand's disease. Proc Natl Acad Sci USA 82:5968\u20135972","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01910317_CR13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V68.6.1207.1207","volume":"68","author":"J Battle","year":"1986","unstructured":"Battle J, Lopez-Fernandez MF, Campos M, Zimmerman TS (1986) The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors. Blood 68:1207\u20131212","journal-title":"Blood"},{"key":"BF01910317_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647265","volume":"64","author":"A Casonato","year":"1990","unstructured":"Casonato A, Sartori MT, De Marco L, Girolami A (1990) 1-Desamino-8d arginin vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of variable pseudothrombocytopenia. Thromb Haemost 64:117\u2013119","journal-title":"Thromb Haemost"},{"key":"BF01910317_CR15","first-page":"309","volume":"29","author":"A Casonato","year":"1985","unstructured":"Casonato A, Fabris F, Vicariotto M, Girolami A (1985) The evaluation of factor VIII antigen by means of a simple slide test. Am J Clin Pathol 29:309\u2013316","journal-title":"Am J Clin Pathol"},{"key":"BF01910317_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.1970.tb01615.x","volume":"19","author":"A Girolami","year":"1970","unstructured":"Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A (1970) A new congenital haemorrhagic condition due to the presence of normal factor X (factor X Friuli); study of a large kindred. Br J Haematol 19:179\u2013192","journal-title":"Br J Haematol"},{"key":"BF01910317_CR17","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1182\/blood.V74.6.2028.2028","volume":"74","author":"A Casonato","year":"1989","unstructured":"Casonato A, De Marco L, Mazzuccato M, De Angelis V, De Ruia A, Fabris F, Ruggeri ZM, Girolami A (1989) A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor-platelet interaction and the presence of all von Willebrand factor multimers in plasma. Blood 74:2028\u20132033","journal-title":"Blood"},{"key":"BF01910317_CR18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V66.6.1423.1423","volume":"66","author":"G Ciavarella","year":"1985","unstructured":"Ciavarella G, Ciavarella N, Antonecchi S, De Mattia D, Ranieri P, Dent J, Zimmerman TS, Ruggeri ZM (1985) High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand's disease with aberrant structure but presence of all size multimers (IIC). Blood 66:1423\u20131429","journal-title":"Blood"},{"key":"BF01910317_CR19","first-page":"411","volume":"101","author":"HJ Weiss","year":"1983","unstructured":"Weiss HJ, Pietu G, Rabinowitz R, Girma J-P, Rogers J, Meyer D (1983) Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII\/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med 101:411\u2013424","journal-title":"J Lab Clin Med"},{"key":"BF01910317_CR20","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","volume":"267","author":"SE Lyons","year":"1992","unstructured":"Lyons SE, Bruck ME, Bowie EJW, Ginsburg D (1992) Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 267:4424\u20134430","journal-title":"J Biol Chem"},{"key":"BF01910317_CR21","first-page":"2344","volume":"69","author":"M Furlan","year":"1993","unstructured":"Furlan M, Robles R, Affolter D, Mayer D, Baillod P, Lammle B (1993) Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Thromb Haemost 69:2344","journal-title":"Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01910317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01910317\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01910317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T09:38:16Z","timestamp":1626255496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01910317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["BF01910317"],"URL":"https:\/\/doi.org\/10.1007\/bf01910317","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}